Nanjing King-friend Biochemical Pharmaceutical Co Ltd - Asset Resilience Ratio

Latest as of March 2026: 10.45%

Nanjing King-friend Biochemical Pharmaceutical Co Ltd (603707) has an Asset Resilience Ratio of 10.45% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check 603707 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets

CN¥1.12 Billion

≈ $163.47 Million USD Cash + Short-term Investments

Total Assets

CN¥10.69 Billion

≈ $1.56 Billion USD All company assets

Resilience Assessment

Moderate

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2025)

This chart shows how Nanjing King-friend Biochemical Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. See Nanjing King-friend Biochemical Pharmace (603707) balance sheet quality index to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Nanjing King-friend Biochemical Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see 603707 company net worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.12 Billion	10.45%
Total Liquid Assets	CN¥1.12 Billion	10.45%

Asset Resilience Insights

Moderate Liquidity: Nanjing King-friend Biochemical Pharmaceutical Co Ltd has 10.45% of assets in liquid form.
While adequate for normal operations, this level may limit flexibility during economic stress.
The company has significant short-term investments, indicating active treasury management.

Nanjing King-friend Biochemical Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio

Compare Nanjing King-friend Biochemical Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	Drug Manufacturers - Specialty & Generic	4.94%
Zhejiang Huahai Pharmaceutical Co Ltd SHG:600521	Drug Manufacturers - Specialty & Generic	0.35%
Bausch Health Companies Inc TO:BHC	Drug Manufacturers - Specialty & Generic	4.97%
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	Drug Manufacturers - Specialty & Generic	24.59%
Curaleaf Holdings Inc. TO:CURA	Drug Manufacturers - Specialty & Generic	3.73%
Shandong Buchang Pharmaceuticals Co Ltd SHG:603858	Drug Manufacturers - Specialty & Generic	3.47%
Shanghai Yizhong Pharmaceutical Co Ltd SHG:688091	Drug Manufacturers - Specialty & Generic	26.36%
China Animal Husbandry Industry Co Ltd SHG:600195	Drug Manufacturers - Specialty & Generic	3.81%

Annual Asset Resilience Ratio for Nanjing King-friend Biochemical Pharmaceutical Co Ltd (2014–2025)

The table below shows the annual Asset Resilience Ratio data for Nanjing King-friend Biochemical Pharmaceutical Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	12.73%	CN¥1.32 Billion ≈ $192.65 Million	CN¥10.34 Billion ≈ $1.51 Billion	+1.63pp
2024-12-31	11.10%	CN¥1.06 Billion ≈ $154.44 Million	CN¥9.51 Billion ≈ $1.39 Billion	+3.94pp
2023-12-31	7.16%	CN¥681.99 Million ≈ $99.80 Million	CN¥9.52 Billion ≈ $1.39 Billion	+7.15pp
2022-12-31	0.01%	CN¥1.30 Million ≈ $190.23K	CN¥10.01 Billion ≈ $1.46 Billion	-3.15pp
2021-12-31	3.16%	CN¥259.80 Million ≈ $38.02 Million	CN¥8.22 Billion ≈ $1.20 Billion	-7.79pp
2020-12-31	10.96%	CN¥845.79 Million ≈ $123.77 Million	CN¥7.72 Billion ≈ $1.13 Billion	+9.84pp
2019-12-31	1.12%	CN¥56.64 Million ≈ $8.29 Million	CN¥5.08 Billion ≈ $743.13 Million	-18.18pp
2017-12-31	19.30%	CN¥520.00 Million ≈ $76.09 Million	CN¥2.69 Billion ≈ $394.33 Million	+5.42pp
2015-12-31	13.87%	CN¥180.00 Million ≈ $26.34 Million	CN¥1.30 Billion ≈ $189.85 Million	+13.77pp
2014-12-31	0.11%	CN¥1.64 Million ≈ $239.56K	CN¥1.54 Billion ≈ $225.37 Million	--

pp = percentage points

About Nanjing King-friend Biochemical Pharmaceutical Co Ltd

SHG:603707 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.69 Billion

CN¥11.54 Billion CNY

Market Cap Rank

#6864 Global

#1531 in China

Share Price

CN¥7.14

Change (1 day)

+0.28%

52-Week Range

CN¥7.08 - CN¥11.94

All Time High

CN¥33.62